Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Reducing the treatment burden can reduce the risk of serious side effects, some of which can endure for years.
Men who have sex with men are at higher risk for the disease, which is driven by human papillomavirus.
Recently approved cancer medications cost more than twice as much in the United States as they do in Europe.
Thousands of people around the world have already received the promising new therapy.
Researchers followed nearly 10,000 people with hepatitis C, some of whom were treated with direct-acting antivirals.
A European study of nearly 19,000 people with HIV also found that curing hep C was not associated with heart disease or non-AIDS cancer.
Timothy Brown may have company after a man’s virus went into remission following an HIV-resistant stem cell transplant to treat his cancer.
That’s compared with using patches, gum, lozenges, sprays, inhalers or a combination of such products.
These drugs, made from living organisms, are big moneymakers partly because they have little competition. It’s a different story in Europe.
This is according to a meta-analysis of a dozen studies conducted in North America and Europe.
The annual scientific meeting on liver health revealed exciting new findings concerning the battle against the hep C epidemic.
This is according to an analysis of nearly 5,000 Italians recently treated for the virus.
Highlights from HIV and hepatitis C research presented at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston
Researchers urge clinicians to closely monitor their patients with HIV and chronic kidney disease.
Known as HPV16, the strain of human papillomavirus is strongly associated with anal cancer.
A recent study found that daily cannabis use was associated with a reduced risk of the liver condition in this population.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.